Ok. My knowledge is as follows. Each NHS Trust has a Clinical Commissioning Group (CCG) who sit "above" the Trust in question. A CCG autonomous I.e. does not report to the Trust but does hold the purse strings. Their job, is to commission the services needed for the population served by that Trust. That will include, numbers of staff, equipment prescribed, which services they think are needed. This explains why Libre sensors did not roll out nationally at precisely the same time everywhere. It will be up to each CCG to choose to commission (fund) sensors as a prescribed device.
CCG's are concerned wirh cost primarily although you will hear them claim they put patients first, if they do it's because they've done the numbers and like the results. But if Abbott is contracted to replace all faulty devices, then it doesn't cost the CCG any more. So, the only way a CCG could be forced to review what they arecl prepared to fund, would be if Libre fails were creating an extra pressure e.g. enough hospital admissions to raise eyebrows. Apart from that happening it dies as you say come down to anecdotal, qualitative evidence which might well be accurate and true......but it's referring to something which isn't causing additional financial burden to each Trust and therefore the CCG's.
That was an extremely dull reply. I live with that same tension in the work place and sometimes I want to smash my head on a wall because of it..........
